Physician
Hutchings, Nicholas
Hutchings, Nicholas was paid $0.00 by Medicaid between May 2022 and Dec 2024, across 92 billing codes. Its largest line is 99212, Office or other outpatient visit for the evaluation and management of an established patient, straightforward — 0% of everything it billed.
33Billing provider infoHUTCHINGS, NICHOLAS
LOS ANGELES, CA 90012
LOS ANGELES, CA 90012
33aNPI1710482690assigned 03/24/2018
33bProvider typeGeneral Practice Physician
28Total paid$0.00
24GClaims43,256
24DCodes billed92
24AFirst – last monthMay 2022 – Dec 2024
Compared with peers
Next to other General Practice Physician providers in California
Rank by total paid#423 of 474
Median peer was paid$10K
This provider vs. median0.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2022 | 3,153 | $0.00 | |
| 2023 | 12,458 | $0.00 | |
| 2024incomplete | 27,645 | $0.00 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 0% | 338 | 325 | $0.00 |
| 82540 | 0% | 648 | 634 | $0.00 | |
| 3051F | 0% | 145 | 145 | $0.00 | |
| 80061 | Lipid panel | 0% | 1,670 | 1,663 | $0.00 |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 0% | 653 | 339 | $0.00 |
| 83540 | 0% | 508 | 499 | $0.00 | |
| 98966 | 0% | 16 | 15 | $0.00 | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 0% | 109 | 109 | $0.00 |
| 77062 | 0% | 94 | 94 | $0.00 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 0% | 3,287 | 2,463 | $0.00 |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 0% | 12 | 12 | $0.00 |
| 90750 | 0% | 160 | 160 | $0.00 |
80 more codes
| 3077F | 0% | 443 | $0.00 | |
| 80076 | 0% | 201 | $0.00 | |
| 3078F | 0% | 1,577 | $0.00 | |
| 82274 | 0% | 353 | $0.00 | |
| 86703 | 0% | 544 | $0.00 | |
| 82570 | 0% | 282 | $0.00 | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 0% | 308 | $0.00 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 75 | $0.00 |
| 3046F | 0% | 120 | $0.00 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 58 | $0.00 |
| 85610 | 0% | 573 | $0.00 | |
| 84100 | 0% | 327 | $0.00 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 115 | $0.00 |
| 99442 | 0% | 58 | $0.00 | |
| 86480 | 0% | 229 | $0.00 | |
| 86705 | 0% | 91 | $0.00 | |
| 84155 | 0% | 15 | $0.00 | |
| 81003 | 0% | 52 | $0.00 | |
| 90661 | 0% | 19 | $0.00 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 0% | 47 | $0.00 |
| 84439 | 0% | 62 | $0.00 | |
| 97161 | 0% | 24 | $0.00 | |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | 0% | 49 | $0.00 |
| 82565 | 0% | 13 | $0.00 | |
| 90653 | 0% | 35 | $0.00 | |
| 99204 | Doctor's office visit, new patient (more involved) | 0% | 29 | $0.00 |
| 85007 | 0% | 31 | $0.00 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 0% | 16 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 82 | $0.00 |
| 99203 | Doctor's office visit, new patient (routine) | 0% | 14 | $0.00 |
| 80048 | Basic metabolic panel (calcium, ionized) | 0% | 1,246 | $0.00 |
| 80053 | Comprehensive metabolic panel | 0% | 2,821 | $0.00 |
| 83036 | Hemoglobin; glycosylated (A1C) | 0% | 2,076 | $0.00 |
| 3075F | 0% | 400 | $0.00 | |
| 87522 | Neg quan hep c or qual rna | 0% | 509 | $0.00 |
| 83735 | 0% | 1,203 | $0.00 | |
| 81001 | 0% | 442 | $0.00 | |
| 82043 | 0% | 648 | $0.00 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 0% | 2,698 | $0.00 |
| 3074F | 0% | 1,104 | $0.00 | |
| 90656 | 0% | 121 | $0.00 | |
| 99213 | Doctor's office visit, returning patient (routine) | 0% | 2,327 | $0.00 |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 400 | $0.00 |
| 85652 | 0% | 265 | $0.00 | |
| 85027 | 0% | 647 | $0.00 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 0% | 162 | $0.00 |
| 86780 | 0% | 157 | $0.00 | |
| 99214 | Doctor's office visit, returning patient (more involved) | 0% | 823 | $0.00 |
| 90686 | 0% | 108 | $0.00 | |
| 82607 | 0% | 382 | $0.00 | |
| 86141 | 0% | 301 | $0.00 | |
| 3079F | 0% | 299 | $0.00 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 5,677 | $0.00 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 942 | $0.00 |
| 97010 | 0% | 211 | $0.00 | |
| 3052F | 0% | 28 | $0.00 | |
| 86706 | 0% | 149 | $0.00 | |
| 83550 | 0% | 504 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 779 | $0.00 |
| 3044F | 0% | 568 | $0.00 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 75 | $0.00 |
| 99443 | 0% | 22 | $0.00 | |
| 92227 | 0% | 13 | $0.00 | |
| 82746 | 0% | 193 | $0.00 | |
| 96375 | Therapeutic injection; each additional sequential IV push | 0% | 93 | $0.00 |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 77 | $0.00 |
| 85730 | 0% | 53 | $0.00 | |
| 87340 | 0% | 109 | $0.00 | |
| 82728 | 0% | 530 | $0.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 81 | $0.00 |
| 3080F | 0% | 86 | $0.00 | |
| 1111F | 0% | 260 | $0.00 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 0% | 47 | $0.00 |
| 84153 | 0% | 18 | $0.00 | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 0% | 37 | $0.00 |
| 85008 | 0% | 27 | $0.00 | |
| 92250 | 0% | 16 | $0.00 | |
| 99441 | 0% | 14 | $0.00 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 0% | 12 | $0.00 |
| 1220F | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.